ArticleAAPS PharmSciTech2025
Dissolution Amelioration by Small Amounts of HPMC in the Difficult-to-solve Drug Combination Baicalein-imperatorin Co-Amorphous System: Dispersion and Crystallization Inhibition.
Article in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-drug co-amorphous systems (CAS) represent an emerging co-delivery strategy for combination therapy. Current research primarily explores combinations of poorly water-soluble drugs with water-soluble counterparts, while CAS comprising exclusively poorly water-soluble drugs remains underexplored. Such systems may exhibit unique dissolution behaviors due to the absence of hydrophilic components. In prior work, we developed a co-amorphous system of two poorly water-soluble drugs, baicalin (Bai) and imperatorin (Imp). However, this system demonstrated significant agglomeration during dissolution and limited dissolution enhancement. To address this, we incorporated trace hydroxypropyl methylcellulose (HPMC) into the Bai-Imp-CAS via spray drying. This study investigates HPMC's impact on dissolution behavior and underlying mechanisms through comprehensive analyses of supersaturation dissolution, dispersion kinetics, agglomeration rate, contact angle, surface free energy, nucleation time, and crystal growth rate. Results indicate that trace HPMC significantly enhances dissolution performance by reducing contact angles and increasing surface free energy, thereby improving dispersibility and inhibiting recrystallization. Additionally, HPMC elevates the glass transition temperature (Tg), improving physical stability. These findings provide a novel theoretical framework for optimizing poorly soluble drug combinations and offer practical solutions for co-delivery system development.Finally, it is also important to note that the degree of improvement of HPMC on the dissolution of the two drugs in the difficult-to-dissolve drug combination is also related to the solubility of the drugs themselves, their crystallization properties and the ratio of the two drugs.
Indexed as
Identifiers
41053235What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.